Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, and promotion of branded prescription pharmaceutical products in the gastroenterology, women's healthcare, dermatology, and urology segments in North America and western Europe. The company primarily offers Ulcerative Colitis ASACOL and ASACOL for the treatment of ulcerative colitis and maintenance of remission; and ACTONEL for the prevention and treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and FEMCON FE for the prevention of pregnancy; and ESTRACE cream for treatment of vaginal and vulvar atrophy. It also provides DORYX, an oral adjunctive therapy for severe acne; ENABLEX for the treatment of overactive bladder; FEMHRT for combined estrogen-progestogen therapy; and various dermatology products, such as TACLONEX, TACLONEX SCALP, and DOVONEX. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug and grocery store chains. Warner Chilcott Public Limited Company was founded in 1968 and is based in Ardee, Ireland
